Outbreak of ED visits related to the use of synthetic cannabinoids, Mayotte Island

Description: 

On October 2016, the Indian Ocean Regional Health Agency was alerted about an increase in ED visits related to adverse reactions associated with use of SC on Mayotte Island. In this context, an investigation based on a syndromic surveillance system was implemented by the regional unit of the French national public health agency.

Objective:

To confirm and to characterize the increase in emergency department (ED) visits related to the use of synthetic cannabinoids (SC).

Primary Topic Areas: 
Original Publication Year: 
2018
Event/Publication Date: 
January, 2018

January 21, 2018

Contact Us

NSSP Community of Practice

Email: syndromic@cste.org

 

This website is supported by Cooperative Agreement # 6NU38OT000297-02-01 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health between the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. CDC is not responsible for Section 508 compliance (accessibility) on private websites.

Site created by Fusani Applications